About MHAT Trimontium OOD
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Clinical Trials at MHAT Trimontium OOD
During the past decade, MHAT Trimontium OOD conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 6 clinical trials were completed, i.e. on
average, 85.7% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 4 clinical trials were completed. i.e. 200%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "MHAT Trimontium OOD"
#1 collaborator was "Hospira, now a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at MHAT Trimontium OOD
According to Clinical.Site data, the most researched conditions in "MHAT Trimontium OOD" are
"Arthritis, Rheumatoid" (2 trials), "Psoriatic Arthritis" (2 trials), "Ankylosing Spondylitis" (1 trials), "Arthritis, Psoriatic" (1 trials) and "Lupus Erythematosus, Systemic" (1 trials). Many other conditions were trialed in "MHAT Trimontium OOD" in a lesser frequency.
Clinical Trials Intervention Types at MHAT Trimontium OOD
Most popular intervention types in "MHAT Trimontium OOD" are "Drug" (7 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (3 trials), "BI 695501" (2 trials), "CT-P13" (1 trials), "EU-Humira" (1 trials) and "Guselkumab" (1 trials). Other intervention names were less common.
Clinical Trials Genders at MHAT Trimontium OOD
The vast majority of trials in "MHAT Trimontium OOD" are
7 trials for "All" genders.
Clinical Trials Status at MHAT Trimontium OOD
Currently, there are NaN active trials in "MHAT Trimontium OOD".
undefined are not yet recruiting,
1 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 5 completed trials in MHAT Trimontium OOD,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in MHAT Trimontium OOD, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 5 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".